Your session is about to expire
← Back to Search
Levetiracetam for Seizures (SPAR Trial)
SPAR Trial Summary
This trial is investigating whether a common practice of giving anti-epileptic drugs to patients before surgery to prevent seizures has any utility.
- Seizures
- Intracranial Aneurysms
SPAR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SPAR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of seizures.You have had a stroke in the past.You have a tumor in your brain.You are allergic to levetiracetam.You are currently pregnant or breastfeeding.You have had a seizure in the last 10 years.
- Group 1: Levetiracetam
- Group 2: No levetiracetam
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has there been further empirical research on Levetiracetam's efficacy?
"At present, 18 clinical trials looking into Levetiracetam are underway with two in Phase 3. Of these studies, a substantial amount take place within Brisbane, Queensland; however there are over 40 sites running investigations for this drug."
Has the FDA sanctioned Levetiracetam as a viable therapeutic drug?
"Levetiracetam is a sanctioned medication and thus received an assessment of 3 from the Power team. This score reflects that it has been approved after undergoing Phase 4 clinical trials."
In what instances is Levetiracetam usually recommended?
"Levetiracetam is often utilized to treat juvenile myoclonic epilepsy and other associated disorders, such as epilepsies and myoclonic seizures in patients with a bodyweight of more than 20 kilograms."
Is the recruitment process for this trial currently underway?
"Unfortunately, according to clinicaltrials.gov this trial is not presently accepting applicants. The initial post was made on February 1st 2013 and the last update occurred on October 21th 2022. However, 259 other trials are actively searching for participants at present."
To what extent is the participant pool for this clinical trial expanding?
"Unfortunately, recruitment for this trial has closed. It was initially posted on February 1st 2013 and the most recent update occured on October 21 2022. If you are looking to join other clinical trials there are 241 studies recruiting participants with seizures and 18 Levetiracetam trials actively searching for volunteers."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger